Results for tag: "Juvenile Arthritis Drug"

The Juvenile Arthritis Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Juvenile Arthritis is an autoimmune disorder that affects children and adolescents, and is characterized by inflammation of the joints. Treatment for Juvenile Arthritis typically involves a combination of medications, physical therapy, and lifestyle changes. Common medications used to treat Juvenile Arthritis include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic agents. The Juvenile Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering treatments. Some of the major players in the market include AbbVie, Pfizer, Novartis, and Johnson & Johnson. Smaller companies such as Horizon Pharma and UCB also offer treatments for Juvenile Arthritis. Show Less Read more